MedTrace Logo

Comparing the Effectiveness of a Safety Intravenous Cannula With a Standard Intravenous Cannula in Neonates

NCT03597711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-03-17

No results posted yet for this study

Summary

A smaller caliber of intravenous cannulae decreases the number of thrombi and phlebitis and improves the duration of peripheral access. It also reduces the incidence of extravasation. 26G cannulae are easier to insert and reduce the number of attempts for cannulation. Safety cannulae are equivalent in terms of durability and ease of insertion, additionally providing a reduction in needle stick injury amongst healthcare professionals and patients.

The goal of this study is to reduce the number of peripheral line insertions and resulting complications in neonates.

The Investigators propose to compare 24G safety and 26G safety cannulae with non-safety 24G cannulae in infants \< 32 weeks Gestation and \< 1.5 kg weight in terms of length of stay of cannula, ease of insertion and rates of complications such as thrombosis, phlebitis and extravasation.

The Investigators will also evaluate the frequency of needle stick injury to staff and patients in the course of the study.

Conditions

  • Preterm Infant

Interventions

DEVICE

IVcannulation

Peripheral venous cannulation is a common procedure on neonatal NICU, especially in preterm infants

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Anna Pawleletz · Manchester University Foundation Trust, Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
23 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2019-07-01
Completion
2019-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597711 on ClinicalTrials.gov